These findings present an interesting contrast with previous research on prostate cancer, where RNASEK downregulation was associated with cancer development, and its overexpression correlated with reduced tumor aggressiveness and improved survival [25]. The gene discussed is RNASEK; the disease is Familial prostate cancer.